购物车
- 全部删除
- 您的购物车当前为空
Ivermectin B1a monosaccharide is produced by selective hydrolysis of the terminal saccharide unit of ivermectin. It can inhibit nematode larval development, but does not cause paralytic activity. This compound has been used as a probe to detect some types of ivermectin resistance.
Ivermectin B1a monosaccharide is produced by selective hydrolysis of the terminal saccharide unit of ivermectin. It can inhibit nematode larval development, but does not cause paralytic activity. This compound has been used as a probe to detect some types of ivermectin resistance.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 840 | 35日内发货 | |
10 mg | ¥ 1,550 | 35日内发货 |
产品描述 | Ivermectin B1a monosaccharide is produced by selective hydrolysis of the terminal saccharide unit of ivermectin. It can inhibit nematode larval development, but does not cause paralytic activity. This compound has been used as a probe to detect some types of ivermectin resistance. |
分子量 | 730.936 |
分子式 | C41H62O11 |
CAS No. | 71837-27-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度信息 | DMSO: Soluble Methanol: Soluble DMF: Soluble Ethanol: Soluble |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容